Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells

Anti-Cancer Drugs

Volumn 17, Issue 3, 2006, Pages 279-287

  Tong, Qiang Song ^a   Zheng, Li Duan ^a   Lu, Peng ^a   Jiang, Feng Chao ^a   Chen, Fang Min ^a   Zeng, Fu Qing ^a   Wang, Liang ^a   Dong, Ji Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Cancer; Curcumin; Derivative

Indexed keywords

CASPASE 3; CURCUMIN; DNA; ESTERASE; ESTERASE INHIBITOR; N MALEOYLGLYCYLCURCUMIN; N MALEOYLVALYLCURCUMIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CELL GROWTH; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; CASPASE 3; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CURCUMIN; EPITHELIAL CELLS; ESTERASES; GROWTH INHIBITORS; HUMANS; KIDNEY TUBULES; URINARY BLADDER NEOPLASMS;

EID: 33646082493     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200603000-00006     Document Type: Article

References (41)

1. Han R. Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China. Chin Med Sci J 1994; 9:61-69.
2. Afaq F, Adhami VM, Ahmad N, Mukhtar H. Botanical antioxidants for chemoprevention of photocarcinogenesis. Front Biosci 2002; 7:d784-d792.
3. Lodha R, Bagga A. Traditional Indian systems of medicine. Ann Acad Med Singapore 2000; 29:37-41.
4. Eigner D, Scholz D. Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J Ethnopharmacol 1999; 6:7-16.
5. Han R. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells 1994; 12:53-63.
6. Anto RJ, George J, Babu KV, Rajasekharan KN, Kuttan R. Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat Res 1996; 370:127-131.
7. Huang MT, Wang ZY, Georgiadis CA, Laskin JD, Conney AH. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 1992; 13:2183-2186.
8. Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, Laskin JD, et al. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 1991; 31:385-396.
9. Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen P, et al. Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]-anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 1998; 19:1697-1700.
10. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 1994; 54:5841-5847.
11. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 1995; 55:259-266.
12. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004; 10:6847-6854.
13. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998; 64:353-356.
14. Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 2000; 7:303-308.
15. Song EK, Cho H, Kim JS, Kim NY, An NH, Kim JA, et al. Diarylheptanoids with free radical scavenging and hepatoprotective activity in vitro from Curcuma longa. Planta Med 2001; 67:876-877.
16. Thapliyal R, Maru GB. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food Chem Toxicol 2001; 39:541-547.
17. Kim JH, Shim JS, Lee SK, Kim KW, Rha SY, Chung HC, et al. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Jpn J Cancer Res 2002; 93:1378-1385.
18. Leyon PV, Kuttan G. Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J Exp Clin Cancer Res 2003; 22:77-83.
19. Shim JS, Kim DH, Jung HJ, Kim JH, Lim D, Lee SK, et al. Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation. Bioorg Med Chem 2002; 10:2439-2444.
20. Kumar AP, Garcia GE, Ghosh R, Rajnarayanan RV, Alworth WL, Slaga TJ. 4-Hydroxy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway: potential for prostate cancer management. Neoplasia 2003; 5:255-266.
21. Qureshi S, Shah AH, Ageel AM. Toxicity studies on Alpinia galanga and Curcuma longa. Planta Med 1992; 58:124-127.
22. Sahu SC, Washington MC. Effect of ascorbic acid and curcumin on quercetin-induced nuclear DNA damage, lipid peroxidation and protein degradation. Cancer Lett 1992; 63:237-241.
23. Blasiak J, Trzeciak A, Malecka-Panas E, Drzewoski J, Iwanienko T, Szumiel I, et al. DNA damage and repair in human lymphocytes and gastric mucosa cells exposed to chromium and curcumin. Teratog Carcinog Mutagen 1999; 19:19-31.
24. Blasiak J, Trzeciak A, Kowalik J. Curcumin damages DNA in human gastric mucosa cells and lymphocytes. J Environ Pathol Toxicol Oncol 1999; 18:271-276.
25. Riordan HD, Riordan NH, Meng X, Zhong J, Jackson JA. Improved microplate fluorometer counting of viable tumor and normal cells. Anticancer Res 1994; 14:927-931.
26. Morishita Y, Fujii M, Kasakura Y, Takayama T. Effect of carboxylesterase inhibition on the anti-tumour effects of irinotecan. J Int Med Res 2005; 33:84-89.
27. Leite M, Quinta-Costa M, Leite PS, Guimaraes JE. Critical evaluation of techniques to detect and measure cell death - study in a model of UV radiation of the leukaemic cell line HL60. Anal Cell Pathol 1999; 19:139-151.
28. Overbeeke R, Steffens-Nakken H, Vermes I, Reutelingsperger C, Haanen C. Early features of apoptosis detected by four different flow cytometry assays. Apoptosis 1998; 3:115-121.
29. Jovanovic SV, Boone CW, Steenken S, Trinoga M, Kaskey RB. How curcumin works preferentially with water soluble antioxidants. J Am Chem Soc 2001; 123:3064-3068.
30. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998; 4:376-383.
31. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 1998; 9:305-312.
32. Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des 2002; 8:1695-1706.
33. Simon A, Allais DP, Duroux JL, Basly JP, Durand-Fontanier S, Delage C. Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett 1998; 129:111-116.
34. Dinkova-Kostova AT, Talalay P. Relation of structure of curcumin analogs to their potencies as inducers of phase 2 detoxification enzymes. Carcinogenesis 1999; 20:911-914.
35. Mazumder A, Neamati N, Sunder S, Schulz J, Pertz H, Eich E, et al. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J Med Chem 1997; 40:3057-3063.
36. Hahm ER, Cheon G, Lee J, Kim B, Park C, Yang CH. New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. Cancer Lett 2002; 1:848-996.
37. Ishida J, Ohtsu H, Tachibana Y, Nakanishi Y, Bastow KF, Nagai M, et al. Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents. Bioorg Med Chem 2002; 10:3481-3487.
38. Lin CC, Ho CT, Huang MT. Mechanistic studies on the inhibitory action of dietary dibenzoylmethane, a beta-diketone analogue of curcumin, on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis. Proc Natl Sci Counc Repub China B 2001; 25:158-165.
39. Denny WA. Prodrug strategies in cancer therapy. Eur J Med Chem 2001; 36:577-595.
40. Zheng L, Tong Q, Wu C. Growth-inhibitory effects of curcumin on ovary cancer cells and its mechanisms. J Huazhong Univ Sci Technol Med Sci 2004; 24:55-58.
41. Jana NR, Dikshit P, Goswami A, Nukina N. Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem 2004; 279:11680-11685.